医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Korean Food Manufacturer JEJUMAMI Launches Snacks for Kids from Clean Jeju

2019年07月26日 AM11:00
このエントリーをはてなブックマークに追加


 

JEJU, South Korea

To parents who are looking for healthy and reliable foods for their children, JEJUMAMI offers Hokkeullak Chips, grain snacks made by mothers in Jeju, South Korea.

JEJUMAMI’s signature Hokkeullak Chips are puffed grain food snacks made of black barleys from Jeju. It contains Jeju black barley, sun-dried sea salt, and enzyme-treated stevia. Enzyme-treated stevia is a natural sweetener featuring a healthy sweetness with low calories. It can also stabilize blood sugar, making it a good sugar substitute for people with diabetes or on a diet.

The chips do not just provide a great texture and taste but a visual delight with its horse- and hareubang (Jeju’s stone statue) -like figure.

The chips are sold in Innisfree Green Cafe, Jeju Air’s Air Cafe, Caffe Bene, Hyatt Regency Jeju, and Ramada Plaza Jeju. They can also be purchased at online shopping malls such as Market Kurly and Coupang.

The product was selected as Top 10 Must Buy In Jeju 2017 and awarded a grand prize from Korean Processed Rice Food and Traditional Liquor Festival 2018.

JEJUMAMI’s other products, such as Jejubabsim Scorched Rice and Jejubabsang (Jeju local food table) Nutritious Rice, include a variety of foods made by ingredients from Jeju.

“I developed Hokkeullak Chips as a mother who is eager to provide children with healthy food only,” said Kim Jeong-ok, a president of JEJUMAMI. “JEJUMAMI means ‘magical rice from Jeju’ and we will develop processed rice foods made of Jeju’s healthy local ingredients to live up to the name.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005345/en/

CONTACT

For JEJUMAMI Co., Ltd.

ADExpo Korea Co., Ltd.

Jinju Lee, +82-2-6010-1101

adexpo@adexpo.co.kr

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • LetsGetChecked、FDAのEUA承認を受けた在宅型コロナウイルス(COVID-19)検査用シュア・トラック・テストを発表
  • 欧盟委员会同意武田无需履行剥离夏尔后续化合物SHP647的承诺
  • Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment, Showing Improvement in Recovery Time
  • Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer
  • ENHERTU® Significantly Improved Tumor Response Rate and Overall Survival in HER2 Positive Metastatic Gastric Cancer in Pivotal Phase 2 DESTINY-Gastric01 Trial